This course is discontinued

Teaching plan

DateTeacherPlaceTopicLecture notes / comments
19.01.2009Jan Abel Olsen  12.15-14.00, Forskningsveien 2B  Introduction. Overview of the methodologies; CBA vs CEA. Efficiency; markets and market failures. Positive and normative issues.   
26.01.2009Eline Aas  12.15-16.00, Seminarrom 6, Harald Schjelderups hus  Cost concepts and costs in economic evaluation. Average, marginal and Incremental costs    
02.02.2009Eline Aas  12.15-16.00, Seminarrom 6, Harald Schjelderups hus   Private vs social costs. Time costs Production losses.   
09.02.2009Eline Aas  12.15-16.00, Seminarrom 6, Harald Schjelderups hus   Discounting costs and health effects.   
16.02.2009Jan Abel Olsen  12.15-14.00, Seminarrom 4, Harald Schjelderups hus   CBA – valuing benefits/outcomes in money terms. WTP and production gains.   
17.02.2009Jan Abel Olsen  10.15-12.00, Seminarrom 3, Harald Schjelderups hus   On CBA: WTP and production gains  Seminar 
23.02.2009Jan Abel Olsen  12.15-15.00, Seminarrom 6, Harald Schjelderups hus   CEA/CUA – valuing benefits/ outcomes in health terms. QALYs   
02.03.2009Ivar S. Kristiansen  12.15-15.00, Seminarrom 6, Harald Schjelderups hus   Applied CEA. Translating end-points used in clinical trials to CEA/CUA type units.   
09.03.2009Ivar S. Kristiansen  12.15-15.00, Seminarrom 6, Harald Schjelderups hus   Modelling. From risk-reductions to increased life-time and/or improved health status Modelling II: computer exercise.   
16.03.2009Ivar S. Kristiansen  12.15-15.00, Seminarrom 6, Harald Schjelderups hus  ICER, Sensitivity analyses, deterministic and probabilistic.    
23.03.2009Jan Abel Olsen  12.15-15.00, Seminarrom 6, Harald Schjelderups hus   Efficiency vs equity; fair distributions, priority setting The application of CEA and CBA in health policy; guidelines.   
14.04.2009Ivar S. Kristiansen  08.00-12.00, Seminarrom 1, Harald Schjeldrups Hus  Ekstraforelesning   
12.05.2009  09.00-13.00  EXAM   
Published Oct. 29, 2008 2:36 PM - Last modified Mar. 16, 2009 12:03 PM